These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26542054)
1. Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro. Liang B; Zhan Y; Huang X; Gu E; Dai D; Cai J; Hu G Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):759-765. PubMed ID: 26542054 [TBL] [Abstract][Full Text] [Related]
2. Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro. Wang Z; Wang L; Xu RA; Zhan YY; Huang CK; Dai DP; Cai JP; Hu GX Drug Des Devel Ther; 2016; 10():1909-16. PubMed ID: 27354764 [TBL] [Abstract][Full Text] [Related]
3. Effect of 22 CYP2D6 variants found in the Chinese population on tolterodine metabolism in vitro. Wang H; Dai DP; Sun P; Xu LP; Liang BQ; Cai JP; Hu GX Chem Biol Interact; 2017 Feb; 264():10-15. PubMed ID: 28087463 [TBL] [Abstract][Full Text] [Related]
4. Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro. Cai J; Dai DP; Geng PW; Wang SH; Wang H; Zhan YY; Huang XX; Hu GX; Cai JP Basic Clin Pharmacol Toxicol; 2016 Mar; 118(3):190-9. PubMed ID: 26310775 [TBL] [Abstract][Full Text] [Related]
5. Functional characterization of 22 novel CYP2D6 variants for the metabolism of Tamoxifen. Hu XX; Zhou Q; Lan T; Huang XX; Liang BQ; Dai DP; Cai JP; Hu GX J Pharm Pharmacol; 2016 Jun; 68(6):819-25. PubMed ID: 27109434 [TBL] [Abstract][Full Text] [Related]
6. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Zhou SF Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501 [TBL] [Abstract][Full Text] [Related]
7. Comparison of catalytical activity and stereoselectivity between the recombinant human cytochrome P450 2D6.1 and 2D6.10. Kong LM; Qian MR; Hu HH; Xu SY; Yu LS; Jiang HD; Chen SQ; Zeng S Pharmazie; 2012 May; 67(5):440-7. PubMed ID: 22764579 [TBL] [Abstract][Full Text] [Related]
8. Assessment of 25 CYP2D6 alleles found in the Chinese population on propafenone metabolism in vitro. Su Y; Liang BQ; Feng YL; Zhan Y; Gu E; Chen X; Dai DP; Hu GX; Cai JP Can J Physiol Pharmacol; 2016 Aug; 94(8):895-9. PubMed ID: 27203132 [TBL] [Abstract][Full Text] [Related]
9. Functional characterization of wild-type and 49 CYP2D6 allelic variants for N-desmethyltamoxifen 4-hydroxylation activity. Muroi Y; Saito T; Takahashi M; Sakuyama K; Niinuma Y; Ito M; Tsukada C; Ohta K; Endo Y; Oda A; Hirasawa N; Hiratsuka M Drug Metab Pharmacokinet; 2014; 29(5):360-6. PubMed ID: 24647041 [TBL] [Abstract][Full Text] [Related]
10. Effects of 24 CYP2D6 Variants Found in the Chinese Population on the Metabolism of Risperidone. Wang ZH; Zhan YY; Li YX; Yang CC; Cai J; Dai DP; Hu GX; Cai JP Pharmacology; 2015; 96(5-6):290-5. PubMed ID: 26544071 [TBL] [Abstract][Full Text] [Related]
11. Effect of CYP2D6 genetic polymorphism on the metabolism of citalopram in vitro. Hu XX; Yuan LJ; Fang P; Mao YH; Zhan YY; Li XY; Dai DP; Cai JP; Hu GX Drug Metab Pharmacokinet; 2016 Apr; 31(2):133-8. PubMed ID: 27016952 [TBL] [Abstract][Full Text] [Related]
12. Effect of 24 Cytochrome P450 2D6 Variants Found in the Chinese Population on Atomoxetine Metabolism in vitro. Liang B; Zhan Y; Wang Y; Gu E; Dai D; Cai J; Hu G Pharmacology; 2016; 97(1-2):78-83. PubMed ID: 26666748 [TBL] [Abstract][Full Text] [Related]
13. Effects of 22 CYP2D6 Genetic Variations Newly Identified in Chinese Population on Olanzapine Metabolism in vitro. Zhou HY; Gu EM; Chen QL; Zhan YY; Wang SH; Liang BQ; Dai DP; Cai JP; Hu GX Pharmacology; 2016; 98(3-4):124-33. PubMed ID: 27251229 [TBL] [Abstract][Full Text] [Related]
14. Effect of 24 cytochrome P450 2D6 variants found in the Chinese population on the N-demethylation of amitriptyline in vitro. Weng Q; Liang B; Zhou Y; Li X; Wang H; Zhan Y; Dai D; Cai J; Hu G Pharm Biol; 2016 Nov; 54(11):2475-2479. PubMed ID: 27097346 [TBL] [Abstract][Full Text] [Related]
15. Effect of CYP2D6 variants on venlafaxine metabolism in vitro. Zhan YY; Liang BQ; Wang H; Wang ZH; Weng QH; Dai DP; Cai JP; Hu GX Xenobiotica; 2016; 46(5):424-9. PubMed ID: 26406933 [TBL] [Abstract][Full Text] [Related]
16. Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro. Fang P; Zheng X; He J; Ge H; Tang P; Cai J; Hu G Drug Des Devel Ther; 2017; 11():1283-1290. PubMed ID: 28461741 [TBL] [Abstract][Full Text] [Related]
17. Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17. Shen H; He MM; Liu H; Wrighton SA; Wang L; Guo B; Li C Drug Metab Dispos; 2007 Aug; 35(8):1292-300. PubMed ID: 17470523 [TBL] [Abstract][Full Text] [Related]
18. In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population. Dai DP; Geng PW; Wang SH; Cai J; Hu LM; Nie JJ; Hu JH; Hu GX; Cai JP Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):39-43. PubMed ID: 25469868 [TBL] [Abstract][Full Text] [Related]
19. Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation. Saito T; Gutiérrez Rico EM; Kikuchi A; Kaneko A; Kumondai M; Akai F; Saigusa D; Oda A; Hirasawa N; Hiratsuka M Drug Metab Pharmacokinet; 2018 Dec; 33(6):250-257. PubMed ID: 30366777 [TBL] [Abstract][Full Text] [Related]
20. Catalytic roles of CYP2D6.10 and CYP2D6.36 enzymes in mexiletine metabolism: in vitro functional analysis of recombinant proteins expressed in Saccharomyces cerevisiae. Hanioka N; Okumura Y; Saito Y; Hichiya H; Soyama A; Saito K; Ueno K; Sawada J; Narimatsu S Biochem Pharmacol; 2006 Apr; 71(9):1386-95. PubMed ID: 16527257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]